In earlier studies, researchers found that CD34(+) cells in RA patients are regulated by TNF∝ and can differentiate into fibroblast-like cells, suggesting that bone marrow CD34+ could be the origin of RASFs [24]. The gene discussed is CD34; the disease is rheumatoid arthritis.